Luc Teyton

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 4 EPO patents. Top assignees: Scripps Research Institute, Brigham Young University, The University of Chicago. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luc Teyton. Retrieved from https://idiyas.com/inventor/luc-teyton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 45.5

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 34(Granted Patents)

Company Filing History:

11 out of 1,206

Scripps Research Institute

patents

10 out of 479

Brigham Young University

patents

10 out of 964

The University of Chicago

patents

4. 1 out of 18

Universitätsmedizin Der Johannes Gutenberg-Universitat Mainz

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12748111 - Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors (2026-09-29),

2. 9295722 - Bacterial glycolipid activation of CD1d-restricted NKT cells (2016-03-29),

3. 9045512 - 6″-amino-6″-deoxygalactosylceramides (2015-06-02),

4. 8932594 - Adjuvants and methods of use (2015-01-13),

5. 8765692 - Modified-galactosyl ceramides for staining and stimulating natural killer T cells (2014-07-01),

6. 8445272 - Method of stimulating NKT with 6″-amino-6″-deoxygalactosylceramides (2013-05-21),

7. 8227581 - Modified α-galactosyl ceramides for staining and stimulating natural killer T cells (2012-07-24),

8. 7998739 - Methods of activating NKT cells (2011-08-16),

9. 7989423 - 6″-amino-6″-deoxygalactosylceramides (2011-08-02),

10. 7794722 - Adjuvants and methods of use (2010-09-14),

11. 7645873 - 6″-amino-6″-deoxygalactosylceramides (2010-01-12),

Title: The Innovative Mind of Luc Teyton

Introduction: Luc Teyton, a distinguished inventor hailing from Del Mar, California, is renowned for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Luc Teyton holds several patents in the areas of immunology, vaccine development, and personalized medicine, showcasing his commitment to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning over two decades, Luc Teyton has held key research positions in leading biotech companies and academic institutions, where he has spearheaded projects that have revolutionized the understanding of the human immune system.

Collaborations: Throughout his career, Luc Teyton has collaborated with top researchers, scientists, and medical professionals globally, fostering a culture of innovation and knowledge exchange in the pursuit of advancing healthcare solutions.

Conclusion: Luc Teyton's relentless pursuit of innovation and his passion for improving human health have solidified his reputation as a visionary inventor in the field of biotechnology, leaving an indelible mark on the scientific community.

Profile summary based on public USPTO records.